Quest Diagnostics Incorporated updated earnings guidance for the full year of 2024. For the year, the company expects net revenues to be between $9.40 billion to $9.48 billion, Net revenues increase to be between 1.6% to 2.5%, Reported diluted EPS to be between $7.57 to $7.82 compared to the previous guidance of net revenues to be between $9.35 billion to $9.45 billion, Net revenues increase to be between 1.1% to 2.1%, Reported diluted EPS to be between $7.69 to $7.99.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.1 USD | -0.58% | -1.48% | -1.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.26% | 15.21B | |
+14.31% | 82.36B | |
-30.46% | 69.97B | |
+11.55% | 29.41B | |
+1.46% | 17.08B | |
-11.30% | 16.99B | |
+2.64% | 13.25B | |
+62.55% | 12.12B | |
+29.68% | 12.08B | |
+52.71% | 11.88B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024